Cargando…

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

BACKGROUND: Total CD4(+) T-cell counts predict HIV disease progression but do not necessarily reflect normalization of immune function. CD4/CD8 ratio is a marker of immune dysfunction, a prognostic indicator for non-AIDS mortality, and reflects viral reservoir size. Despite antiretroviral therapy (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thornhill, John, Inshaw, Jamie, Kaleebu, Pontiano, Cooper, David, Ramjee, Gita, Schechter, Mauro, Tambussi, Giuseppe, Fox, Julie, Samuel, Miriam, Miro, Jose M., Weber, Jonathan, Porter, Kholoud, Fidler, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981213/ https://www.ncbi.nlm.nih.gov/pubmed/27070122 http://dx.doi.org/10.1097/QAI.0000000000001013

Ejemplares similares

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
por: Martin, Genevieve E., et al.
Publicado: (2018)

Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort
por: Granger, Luke A., et al.
Publicado: (2021)

Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults
por: Mugisha, Joseph O, et al.
Publicado: (2012)

Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection
por: Hamlyn, Elizabeth, et al.
Publicado: (2012)

CD4:CD8 ratio in children with perinatally acquired HIV‐1 infection
por: Seers, T, et al.
Publicado: (2018)

Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials
por: Schechter, Mauro
Publicado: (2018)

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)
por: Guiguet, Marguerite, et al.
Publicado: (2008)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa
por: Skhosana, Mandisa, et al.
Publicado: (2016)

Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda
por: Masiira, Ben, et al.
Publicado: (2014)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens
por: Nakiboneka, Ritah, et al.
Publicado: (2019)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery
por: Thornhill, John Patrick, et al.
Publicado: (2017)

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection
por: Fidler, Sarah, et al.
Publicado: (2017)

CD8(+) T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4(+) T Cells <200 Cell/μL: The DART Trial STI Substudy
por: Serwanga, Jennifer, et al.
Publicado: (2011)

‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
por: Mayanja, Yunia, et al.
Publicado: (2017)

Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection
por: Burns, JE, et al.
Publicado: (2021)

Brief report: Decreased expression of CD244 (SLAMF4) on monocytes and platelets in patients with systemic lupus erythematosus
por: Mak, Anselm, et al.
Publicado: (2017)

Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies
por: Wolbers, Marcel, et al.
Publicado: (2010)

A Qualitative Exploration of Causes of Depression among Persons Living with HIV Receiving Antiretroviral Therapy in Uganda: Implications for Policy
por: Rutakumwa, Rwamahe, et al.
Publicado: (2023)

Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals
por: Wang, Sunpeng, et al.
Publicado: (2015)

The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis
por: Salome, Tino, et al.
Publicado: (2016)

Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy–evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011
por: Kazooba, Patrick, et al.
Publicado: (2018)

Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure
por: Lodi, Sara, et al.
Publicado: (2013)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
por: Hurst, Jacob, et al.
Publicado: (2015)

Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy
por: Kazooba, Patrick, et al.
Publicado: (2017)

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4(+) T-cell recovery once HIV-1 suppression is achieved?
por: Jarrin, Inma, et al.
Publicado: (2015)

COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort
por: Mayanja, Billy Nsubuga, et al.
Publicado: (2017)

Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy
por: Leung, Victor, et al.
Publicado: (2013)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Impact on life expectancy of HIV-1 positive individuals of CD4(+) cell count and viral load response to antiretroviral therapy
por: May, Margaret T., et al.
Publicado: (2014)

Assessment of the Impact of Rapid Point-of-Care CD4 Testing in Primary Healthcare Clinic Settings: A Survey Study of Client and Provider Perspectives
por: Reddy, Shabashini, et al.
Publicado: (2020)

Microbicides for HIV prevention
por: Ramjee, Gita
Publicado: (2011)

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
por: Calmy, Alexandra, et al.
Publicado: (2012)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression
por: Martinelli, Marcella, et al.
Publicado: (2016)

The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment
por: Bernal, Enrique, et al.
Publicado: (2014)

Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment
por: Briceño, Olivia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_69obnvuj0s5abamvtb753it572